Suchergebnisse - "Zhang, Lixiu"

PubPharm (48)

1

Pharmacokinetics and safety of a new generic lurasidone : a phase I bioequivalence study in healthy Chinese subjects

enthalten in: Naunyn-Schmiedeberg's archives of pharmacology | 2024

von Liu, Z. | Xue, J. | Deng, Q. | +16

2

Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage

enthalten in: Anti-cancer agents in medicinal chemistry | 2024

von Fan, N. | Zhang, L. | Wang, Z. | +2

3

Evaluation of Measurement Properties of Supportive Environment Assessment Scales for Dementia Special Care Units : A COSMIN Systematic Review

enthalten in: Journal of the American Medical Directors Association | 2023

von Liu, G. | Wu, B. | Han, S. | +4

4

Research on Defect Detection in Kubo Peach Based on Hyperspectral Imaging Technology Combined with CARS-MIV-GA-SVM Method

enthalten in: Foods (Basel, Switzerland) | 2023

von Zhang, L. | Nie, P. | Zhang, S. | +2

5

Advances in the Application of Perovskite Materials

enthalten in: Nano-micro letters | 2023

von Zhang, L. | Mei, L. | Wang, K. | +37

6

A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif® in healthy Chinese subjects

enthalten in: Journal of cancer research and clinical oncology | 2023

von Liu, G. | Xue, J. | Wang, Y. | +17

7

Perovskite films with gradient bandgap for self-powered multiband photodetectors and spectrometers

enthalten in: Nano research | 2023

von Zuo, C. | Zhang, L. | Pan, X. | +10

8

Pharmacokinetics and bioequivalence of sunitinib and Sutent® in Chinese healthy subjects : an open-label, randomized, crossover study

enthalten in: Frontiers in pharmacology | 2023

von Wang, Y. | Deng, Q. | Gao, Z. | +5

9

Enhancement of soil high-molecular-weight polycyclic aromatic hydrocarbon degradation by Fusarium sp. ZH-H2 using different carbon sources

enthalten in: Ecotoxicology and environmental safety | 2023

von Zhang, X. | Zhang, Y. | Wang, X. | +5

10

Traditional Chinese medicine formula for conditioning and treating dysfunction of viscera and use method of traditional Chinese medicine formula

enthalten in: Europäisches Patentamt | 2022

von ZHANG LIXIU

1
2
3
4
5
Nächster »
[5]